Change in sickness behavior assessed with the Sickness Questionnaire after endotoxin challenge is associated with the degree of change in inflammatory cytokines

2017 ◽  
Vol 66 ◽  
pp. e33
Author(s):  
A. Andreasson ◽  
J. Lasselin ◽  
B. Karshikoff ◽  
M.J. Olsson ◽  
J. Axelsson ◽  
...  
2021 ◽  
Vol 5 (3) ◽  
Author(s):  
Jeffery A Carroll ◽  
Nicole C Burdick Sanchez ◽  
Paul R Broadway ◽  
Gleise M Silva ◽  
Juliana Ranches ◽  
...  

Abstract This study evaluated whether administration of lipopolysaccharide (LPS) at each trimester of gestation would alter the acute phase (APR) and metabolic responses to a postnatal LPS challenge in weaned heifers. Pregnant crossbred multiparous cows (n = 50) were randomized into prenatal immune stimulation (PIS; n = 24; administered 0.1 µg/kg BW LPS subcutaneously at 71 ± 2, 170 ± 2 and 234 ± 2 d of gestation) and saline (CON; n = 26) groups. From these treatment groups, heifer calves (n = 12 PIS and 11 CON) were identified at weaning (244 ± 3 d of age) to receive an LPS challenge. On d 0, heifers were fitted with vaginal temperature (VT) devices, jugular catheters, and moved into individual stalls. On d 1, heifers were challenged i.v. with LPS (0.5 µg/kg BW) at 0 h. Blood samples were collected and sickness behavior scores (SBS) recorded at 0.5 h intervals from −2 to 8 h and at 24 h relative to LPS challenge. Serum was analyzed for cortisol, cytokines, glucose, non-esterified fatty acids (NEFA), and serum urea nitrogen (SUN) concentrations. Baseline VT was lesser in PIS heifers from −11 to −5 h pre-LPS (treatment × time: P < 0.01) compared to the CON; however, the post-LPS VT response did not differ between treatments (P = 0.89). There was a treatment × time interaction (P < 0.01) for SBS with PIS heifers having lesser SBS from 0.5 to 2 h post-LPS compared to CON. There was a treatment × time interaction (P = 0.03) for cortisol with PIS heifers having greater cortisol at 0.5, 3, 3.5, 5.5 and 6.5 h post-LPS compared to CON. There were treatment × time interactions for the post-LPS cytokine responses (P ≤ 0.05). Specifically, PIS heifers had greater TNF-α from 1.5 to 2 h, yet less TNF-α at 3 h than CON (P < 0.01), and PIS heifers had greater IFN-γ from 3.5 to 5.5 h post-LPS than CON (P < 0.01). In contrast, IL-6 was less in PIS than CON heifers from 1.5 to 8 h post-LPS (P < 0.001). Glucose concentrations were greater in PIS heifers at −1 h, but less at 2, 3 and 5.5 h compared to CON (treatment × time: P < 0.01). Serum NEFA concentrations were greater (P = 0.04) in PIS than CON heifers. There was a treatment × time interaction (P < 0.01) for SUN with PIS heifers having greater SUN concentrations at −2, −1.5, 2, 3, 6.5 and 24 h than CON. These data demonstrate that in utero exposure to multiple low doses of endotoxin has lasting physiological and immunological effects when the offspring encounter a similar postnatal immunological insult.


2006 ◽  
Vol 8 (2) ◽  
pp. 157-169 ◽  
Author(s):  
Lisa J. Wood ◽  
Lillian M. Nail ◽  
Nancy A. Perrin ◽  
Collin R. Elsea ◽  
April Fischer ◽  
...  

Cancer chemotherapy–related symptoms such as fatigue, malaise, loss of interest in social activities, difficulty concentrating, and changes in sleep patterns can lead to treatment delays, dose reductions, or termination and have a profound effect on the physical, psychosocial, and economic aspects of quality of life. Clinicians have long suspected that these symptoms are similar to those associated with “sickness behavior,” which is triggered by the production of the inflammatory cytokines IL-1β, TNF-α, and IL-6 by macrophages and other cells of the innate immune system in response to immune challenge. The p38 mitogen-activated protein kinase (p38 MAPK) plays a central role in the production of these cytokines and consequently the induction of sickness behavior. Several cancer chemotherapy drugs have been shown to activate p38 MAPK, but whether these drugs can also induce the production of inflammatory cytokines to cause sickness behavior is unknown. The aim of this study was to determine whether the cancer chemotherapy drug etoposide (VP-16), which is known to activate p38 MAPK, could induce inflammatory cytokine production by murine macrophages and sickness-like behaviors when injected into mice. VP-16 activated p38 MAPK and induced IL-6 production in murine macrophages in a p38 MAPK– dependent manner. VP-16 administration rapidly increased serum levels of IL-6 in healthy mice and induced sickness-like behaviors as evidenced by a decrease in food intake, body weight, hemoglobin level, and voluntary wheel-running activity. These findings support the idea that the induction of IL-1β, TNF-α, and IL-6 by cancer chemotherapy drugs underlies the fatigue and associated symptoms experienced by people undergoing cancer chemotherapy.


2015 ◽  
Vol 112 (40) ◽  
pp. 12468-12473 ◽  
Author(s):  
Christine M. Sandiego ◽  
Jean-Dominique Gallezot ◽  
Brian Pittman ◽  
Nabeel Nabulsi ◽  
Keunpoong Lim ◽  
...  

Neuroinflammation is associated with a broad spectrum of neurodegenerative and psychiatric diseases. The core process in neuroinflammation is activation of microglia, the innate immune cells of the brain. We measured the neuroinflammatory response produced by a systemic administration of the Escherichia coli lipopolysaccharide (LPS; also called endotoxin) in humans with the positron emission tomography (PET) radiotracer [11C]PBR28, which binds to translocator protein, a molecular marker that is up-regulated by microglial activation. In addition, inflammatory cytokines in serum and sickness behavior profiles were measured before and after LPS administration to relate brain microglial activation with systemic inflammation and behavior. Eight healthy male subjects each had two 120-min [11C]PBR28 PET scans in 1 d, before and after an LPS challenge. LPS (1.0 ng/kg, i.v.) was administered 180 min before the second [11C]PBR28 scan. LPS administration significantly increased [11C]PBR28 binding 30–60%, demonstrating microglial activation throughout the brain. This increase was accompanied by an increase in blood levels of inflammatory cytokines, vital sign changes, and sickness symptoms, well-established consequences of LPS administration. To our knowledge, this is the first demonstration in humans that a systemic LPS challenge induces robust increases in microglial activation in the brain. This imaging paradigm to measure brain microglial activation with [11C]PBR28 PET provides an approach to test new medications in humans for their putative antiinflammatory effects.


Behaviour ◽  
2020 ◽  
Vol 157 (10-11) ◽  
pp. 855-878
Author(s):  
Weiran Li ◽  
Shuanghong Luo ◽  
Chaomin Wan

Abstract In response to invasion of pathogens, hosts present fever and a series of behavioural changes including reduced grooming, reduction of foraging, decreased locomotion, withdrawing from social activities and reproductive process, which are collectively termed sickness behaviour. Fever as well as sickness behaviour are adaptive and benefit the host to reduce pathology caused by infections and opportunity costs for time away from foraging, reproduction and predator avoidance. Antipathogenic fever and sickness behaviour are mediated proximately by cytokines including pro- and anti-inflammatory cytokines. Pro-inflammation cytokines trigger these sickness responses, while anti-inflammatory cytokines constrain these responses and prevent damage to host from exaggerated responses. The present study reviews the characterization of fever and sickness behaviour regulated by cytokines during infection.


Blood ◽  
2005 ◽  
Vol 106 (11) ◽  
pp. 4569-4569
Author(s):  
Xin S. Wang ◽  
Charles S. Cleeland ◽  
Lori Williams ◽  
James Reuben ◽  
Bang-Ning Lee ◽  
...  

Abstract BMT patients develop multiple symptoms At nadir after transplantation that include pain, fatigue, poor appetite, and disturbed sleep. Animal models of sickness behavior suggest such symptoms may be related to increases in inflammatory cytokines. The objective of this study was to prospectively assess the relationship between symptom severity and changes in inflammatory cytokines. Methods: Weekly symptom assessment with the M. D. Anderson Symptom Inventory was done for 30 AML/MDS patients during the first 100 days of Allo-BMT. A panel of inflammatory cytokines (IL-1ra, IL-6, IL-8, IL-10, IL-12, TNF-a) was assayed at several time points: pre BMT, conditioning, BMT day, BMT Day1, nadir, BMT day14, 21, 28, 60, 90–100. Results: Multiple symptoms peaked at nadir, with some symptoms (fatigue and pain) remaining at high levels after nadir. Figure 1 shows the Lowess curves for selected symptoms on MDASI. Physical symptoms had much larger fluctuation than affective symptoms during the study. Figure 2 presents Lowess curves of the serum levels of cytokines (log base 10). IL-6 and IL-8 showed significant increase during nadir, significantly correlating with fatigue, lack of appetite, drowsiness, dry month, and feeling physically sick (all P<.01). Conclusion: There is an observed relationship between increased symptom severity levels and increased inflammatory cytokine (mainly IL-6 and IL-8) levels during the acute phase of allo-BMT in AML/MDS patients. The question of a causal link between cytokine levels and symptom severity requires further study. Figure Figure Figure Figure


2003 ◽  
Vol 70 ◽  
pp. 125-133 ◽  
Author(s):  
Tim E. Cawston ◽  
Jenny M. Milner ◽  
Jon B. Catterall ◽  
Andrew D. Rowan

We have investigated proteinases that degrade cartilage collagen. We show that pro-inflammatory cytokines act synergistically with oncastatin M to promote cartilage collagen resorption by the up-regulation and activation of matrix metalloproteinases (MMPs). The precise mechanisms are not known, but involve the up-regulation of c-fos, which binds to MMP promoters at a proximal activator protein-1 (AP-1) site. This markedly up-regulates transcription and leads to higher levels of active MMP proteins.


Sign in / Sign up

Export Citation Format

Share Document